BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mittal R, Woo FW, Castro CS, Cohen MA, Karanxha J, Mittal J, Chhibber T, Jhaveri VM. Organ‐on‐chip models: Implications in drug discovery and clinical applications. J Cell Physiol 2019;234:8352-80. [DOI: 10.1002/jcp.27729] [Cited by in Crossref: 105] [Cited by in F6Publishing: 112] [Article Influence: 26.3] [Reference Citation Analysis]
Number Citing Articles
1 Iakovlev AP, Erofeev AS, Gorelkin PV. Novel Pumping Methods for Microfluidic Devices: A Comprehensive Review. Biosensors 2022;12:956. [DOI: 10.3390/bios12110956] [Reference Citation Analysis]
2 De A, Paul S, Reddy N, Sharma V, Bhaumik J, Tippavajhala VK. Lung-on-chip: Its current and future perspective on pharmaceutical and biomedical applications. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103930] [Reference Citation Analysis]
3 Langlie J, Mittal R, Finberg A, Bencie NB, Mittal J, Omidian H, Omidi Y, Eshraghi AA. Unraveling pathological mechanisms in neurological disorders: the impact of cell-based and organoid models. Neural Regen Res 2022;17:2131-40. [PMID: 35259819 DOI: 10.4103/1673-5374.335836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Charlier J, Barkema HW, Becher P, De Benedictis P, Hansson I, Hennig-pauka I, La Ragione R, Larsen LE, Madoroba E, Maes D, Marín CM, Mutinelli F, Nisbet AJ, Podgórska K, Vercruysse J, Vitale F, Williams DJL, Zadoks RN. Disease control tools to secure animal and public health in a densely populated world. The Lancet Planetary Health 2022;6:e812-e824. [DOI: 10.1016/s2542-5196(22)00147-4] [Reference Citation Analysis]
5 Orecchio FM, Tommaso V, Santaniello T, Castiglioni S, Pezzotta F, Monti A, Butera F, Maier JAM, Milani P. A Novel Fluidic Platform for Semi-Automated Cell Culture into Multiwell-like Bioreactors. Micromachines 2022;13:994. [DOI: 10.3390/mi13070994] [Reference Citation Analysis]
6 Zitter R, Chugh RM, Saha S. Patient Derived Ex-Vivo Cancer Models in Drug Development, Personalized Medicine, and Radiotherapy. Cancers (Basel) 2022;14:3006. [PMID: 35740672 DOI: 10.3390/cancers14123006] [Reference Citation Analysis]
7 Chen P, Lin X, Liu A, Li J. The Brain Research Hotspot Database (BRHD): A Panoramic Database of the Latest Hotspots in Brain Research. Brain Sciences 2022;12:638. [DOI: 10.3390/brainsci12050638] [Reference Citation Analysis]
8 Pisanu A, Reid G, Fusco D, Sileo A, Robles Diaz D, Tarhini H, Putame G, Massai D, Isu G, Marsano A. Bizonal cardiac engineered tissues with differential maturation features in a mid-throughput multimodal bioreactor. iScience 2022;25:104297. [DOI: 10.1016/j.isci.2022.104297] [Reference Citation Analysis]
9 Lotsberg ML, Røsland GV, Rayford AJ, Dyrstad SE, Ekanger CT, Lu N, Frantz K, Stuhr LEB, Ditzel HJ, Thiery JP, Akslen LA, Lorens JB, Engelsen AST. Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models. Front Oncol 2022;12:818437. [DOI: 10.3389/fonc.2022.818437] [Reference Citation Analysis]
10 Rivera-arbeláez JM, Cofiño-fabres C, Schwach V, Boonen T, ten Den SA, Vermeul K, van den Berg A, Segerink LI, Ribeiro MC, Passier R. Contractility analysis of human engineered 3D heart tissues by an automatic tracking technique using a standalone application. PLoS ONE 2022;17:e0266834. [DOI: 10.1371/journal.pone.0266834] [Reference Citation Analysis]
11 Nof E, Zidan H, Artzy-Schnirman A, Mouhadeb O, Beckerman M, Bhardwaj S, Elias-Kirma S, Gur D, Beth-Din A, Levenberg S, Korin N, Ordentlich A, Sznitman J. Human Multi-Compartment Airways-on-Chip Platform for Emulating Respiratory Airborne Transmission: From Nose to Pulmonary Acini. Front Physiol 2022;13:853317. [PMID: 35350687 DOI: 10.3389/fphys.2022.853317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zoio P, Oliva A. Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models. Pharmaceutics 2022;14:682. [PMID: 35336056 DOI: 10.3390/pharmaceutics14030682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Vargas R, Egurbide-Sifre A, Medina L. Organ-on-a-Chip systems for new drugs development. ADMET DMPK 2021;9:111-41. [PMID: 35299767 DOI: 10.5599/admet.942] [Reference Citation Analysis]
14 Eintracht J, Harding P, Lima Cunha D, Moosajee M. Efficient embryoid-based method to improve generation of optic vesicles from human induced pluripotent stem cells. F1000Res 2022;11:324. [DOI: 10.12688/f1000research.108829.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Luo L, Ma Y, Zheng Y, Su J, Huang G. Application Progress of Organoids in Colorectal Cancer. Front Cell Dev Biol 2022;10:815067. [PMID: 35273961 DOI: 10.3389/fcell.2022.815067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Arechavala-Gomeza V, Garanto A. Antisense RNA Therapeutics: A Brief Overview. Methods Mol Biol 2022;2434:33-49. [PMID: 35213008 DOI: 10.1007/978-1-0716-2010-6_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu J, Huang X, Huang L, Huang J, Liang D, Liao L, Deng Y, Zhang L, Zhang B, Tang W. Organoid: Next-Generation Modeling of Cancer Research and Drug Development. Front Oncol 2021;11:826613. [PMID: 35155215 DOI: 10.3389/fonc.2021.826613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Langlie J, Finberg A, Bencie NB, Mittal J, Omidian H, Omidi Y, Mittal R, Eshraghi AA. Recent advancements in cell-based models for auditory disorders. Bioimpacts 2022;12:155-169. [DOI: 10.34172/bi.2022.23900] [Reference Citation Analysis]
19 Wan J, Zhou S, Mea HJ, Guo Y, Ku H, Urbina BM. Emerging Roles of Microfluidics in Brain Research: From Cerebral Fluids Manipulation to Brain-on-a-Chip and Neuroelectronic Devices Engineering. Chem Rev 2022. [PMID: 35080375 DOI: 10.1021/acs.chemrev.1c00480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Seidi S, Eftekhari A, Khusro A, Heris RS, Sahibzada MUK, Gajdács M. Simulation and modeling of physiological processes of vital organs in organ-on-a-chip biosystem. Journal of King Saud University - Science 2022;34:101710. [DOI: 10.1016/j.jksus.2021.101710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
21 Jacob EM, Borah A, Sakthi Kumar D. Development of Human-on-a-Chip. Microfluidics and Multi Organs on Chip 2022. [DOI: 10.1007/978-981-19-1379-2_12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Kaur T, Sharma J, Rai S. Tissue Chips: Contemporary Applications and Advancements. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-4345-3_17] [Reference Citation Analysis]
23 Satpathi NS, Hoque SZ, Nampoothiri KN, Malik L, Mirkale K, Desu H, Narendran G, Sen AK. Applications of Microfluidics. Microfluidics and Multi Organs on Chip 2022. [DOI: 10.1007/978-981-19-1379-2_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Salehi Moghaddam A, Salehi Moghaddam Z, Davachi SM, Sarikhani E, Nemati Mahand S, Khonakdar HA, Bagher Z, Ashammakhi N. Recent advances and future prospects of functional organ-on-a-chip systems. Mater Chem Front 2022. [DOI: 10.1039/d2qm00072e] [Reference Citation Analysis]
25 Li M, Stewart AG. Translational Pharmacology and Clinical Trials. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00028-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kaushik P, Kaushik M, Jacob S, Parvez S. Multiorgans-on-a-Chip for Personalized Medicine. Microfluidics and Multi Organs on Chip 2022. [DOI: 10.1007/978-981-19-1379-2_13] [Reference Citation Analysis]
27 Sahoo S, Padhy AA, Kumari V, Shivani K, Mishra P. Therapeutic potential of leucine-rich repeat kinase 2 inhibitors for Parkinson's disease treatment. Protein Kinase Inhibitors 2022. [DOI: 10.1016/b978-0-323-91287-7.00011-9] [Reference Citation Analysis]
28 Sznitman J. Revisiting Airflow and Aerosol Transport Phenomena in the Deep Lungs with Microfluidics. Chem Rev 2021. [PMID: 34964615 DOI: 10.1021/acs.chemrev.1c00621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
29 Kabay G, Manz A, Dincer C. Microfluidic Roadmap for Translational Nanotheranostics. Small Methods 2021;:e2101217. [PMID: 34957704 DOI: 10.1002/smtd.202101217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bale AS, Y CL, N V, Aishwarya, Rao AK, Parinitha BS, Purohit TP. Advancements of Lab on Chip in Reducing Human Intervention: A Study. 2021 3rd International Conference on Advances in Computing, Communication Control and Networking (ICAC3N) 2021. [DOI: 10.1109/icac3n53548.2021.9725466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Barreiro Carpio M, Dabaghi M, Ungureanu J, Kolb MR, Hirota JA, Moran-Mirabal JM. 3D Bioprinting Strategies, Challenges, and Opportunities to Model the Lung Tissue Microenvironment and Its Function. Front Bioeng Biotechnol 2021;9:773511. [PMID: 34900964 DOI: 10.3389/fbioe.2021.773511] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
32 Luo X, She J, Xu T, Zhou Y, Xu C, Jiang J, Li T, Liu H, Shen H, Yin B, Dai B. Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast. Bioengineered 2021;12:11578-85. [PMID: 34874791 DOI: 10.1080/21655979.2021.1974809] [Reference Citation Analysis]
33 Ahsan H. Monoplex and multiplex immunoassays: approval, advancements, and alternatives. Comp Clin Path 2022;31:333-45. [PMID: 34840549 DOI: 10.1007/s00580-021-03302-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Bassan A, Alves VM, Amberg A, Anger LT, Auerbach S, Beilke L, Bender A, Cronin MT, Cross KP, Hsieh J, Greene N, Kemper R, Kim MT, Mumtaz M, Noeske T, Pavan M, Pletz J, Russo DP, Sabnis Y, Schaefer M, Szabo DT, Valentin J, Wichard J, Williams D, Woolley D, Zwickl C, Myatt GJ. In silico approaches in organ toxicity hazard assessment: Current status and future needs in predicting liver toxicity. Computational Toxicology 2021;20:100187. [DOI: 10.1016/j.comtox.2021.100187] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Bassan A, Alves VM, Amberg A, Anger LT, Beilke L, Bender A, Bernal A, Cronin MT, Hsieh J, Johnson C, Kemper R, Mumtaz M, Neilson L, Pavan M, Pointon A, Pletz J, Ruiz P, Russo DP, Sabnis Y, Sandhu R, Schaefer M, Stavitskaya L, Szabo DT, Valentin J, Woolley D, Zwickl C, Myatt GJ. In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities. Computational Toxicology 2021;20:100188. [DOI: 10.1016/j.comtox.2021.100188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Zhang X, Wang W, Jin ZB. Retinal organoids as models for development and diseases. Cell Regen 2021;10:33. [PMID: 34719743 DOI: 10.1186/s13619-021-00097-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
37 Dávila S, Cacheux J, Rodríguez I. Microvessel-on-Chip Fabrication for the In Vitro Modeling of Nanomedicine Transport. ACS Omega 2021;6:25109-15. [PMID: 34632171 DOI: 10.1021/acsomega.1c00735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Dellaquila A, Le Bao C, Letourneur D, Simon-Yarza T. In Vitro Strategies to Vascularize 3D Physiologically Relevant Models. Adv Sci (Weinh) 2021;8:e2100798. [PMID: 34351702 DOI: 10.1002/advs.202100798] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
39 Powell-Palm MJ, Charwat V, Charrez B, Siemons B, Healy KE, Rubinsky B. Isochoric supercooled preservation and revival of human cardiac microtissues. Commun Biol 2021;4:1118. [PMID: 34552201 DOI: 10.1038/s42003-021-02650-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
40 Pang MJ, Burclaff JR, Jin R, Adkins-Threats M, Osaki LH, Han Y, Mills JC, Miao ZF, Wang ZN. Gastric Organoids: Progress and Remaining Challenges. Cell Mol Gastroenterol Hepatol 2022;13:19-33. [PMID: 34547535 DOI: 10.1016/j.jcmgh.2021.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Schneider MR, Oelgeschlaeger M, Burgdorf T, van Meer P, Theunissen P, Kienhuis AS, Piersma AH, Vandebriel RJ. Applicability of organ-on-chip systems in toxicology and pharmacology. Crit Rev Toxicol 2021;51:540-54. [PMID: 34463591 DOI: 10.1080/10408444.2021.1953439] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
42 Artzy-Schnirman A, Arber Raviv S, Doppelt Flikshtain O, Shklover J, Korin N, Gross A, Mizrahi B, Schroeder A, Sznitman J. Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics. Adv Drug Deliv Rev 2021;176:113901. [PMID: 34331989 DOI: 10.1016/j.addr.2021.113901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
43 Chen Z, Anandakrishnan N, Xu Y, Zhao R. Compressive Buckling Fabrication of 3D Cell-Laden Microstructures. Adv Sci (Weinh) 2021;8:e2101027. [PMID: 34263550 DOI: 10.1002/advs.202101027] [Reference Citation Analysis]
44 Zhang MM, Yang KL, Cui YC, Zhou YS, Zhang HR, Wang Q, Ye YJ, Wang S, Jiang KW. Current Trends and Research Topics Regarding Intestinal Organoids: An Overview Based on Bibliometrics. Front Cell Dev Biol 2021;9:609452. [PMID: 34414174 DOI: 10.3389/fcell.2021.609452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Grebenyuk S, Abdel Fattah AR, Rustandi G, Kumar M, Toprakhisar B, Salmon I, Verfaillie C, Ranga A. Engineering large-scale perfused tissues via synthetic 3D soft microfluidics.. [DOI: 10.1101/2021.08.20.457148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Thakare K, Jerpseth L, Pei Z, Elwany A, Quek F, Qin H. Bioprinting of Organ-on-Chip Systems: A Literature Review from a Manufacturing Perspective. JMMP 2021;5:91. [DOI: 10.3390/jmmp5030091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
47 Lu J, Krepelova A, Rasa SMM, Annunziata F, Husak O, Adam L, Nunna S, Neri F. Characterization of an in vitro 3D intestinal organoid model by using massive RNAseq-based transcriptome profiling. Sci Rep 2021;11:16668. [PMID: 34404908 DOI: 10.1038/s41598-021-96321-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Clapp N, Amour A, Rowan WC, Candarlioglu PL. Organ-on-chip applications in drug discovery: an end user perspective. Biochem Soc Trans 2021;49:1881-90. [PMID: 34397080 DOI: 10.1042/BST20210840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
49 Nafshi R, Lezon TR. Predicting the Effects of Drug Combinations Using Probabilistic Matrix Factorization. Front Bioinform 2021;1:708815. [DOI: 10.3389/fbinf.2021.708815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Dash BC, Korutla L, Vallabhajosyula P, Hsia HC. Unlocking the Potential of Induced Pluripotent Stem Cells for Wound Healing: The Next Frontier of Regenerative Medicine. Adv Wound Care (New Rochelle) 2021. [PMID: 34155919 DOI: 10.1089/wound.2021.0049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Kulsharova G, Kurmangaliyeva A. Liver microphysiological platforms for drug metabolism applications. Cell Prolif 2021;:e13099. [PMID: 34291515 DOI: 10.1111/cpr.13099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Munoz-Garcia J, Jubelin C, Loussouarn A, Goumard M, Griscom L, Renodon-Cornière A, Heymann MF, Heymann D. In vitro three-dimensional cell cultures for bone sarcomas. J Bone Oncol 2021;30:100379. [PMID: 34307011 DOI: 10.1016/j.jbo.2021.100379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
53 Zhang Y, Huang S, Zhong W, Chen W, Yao B, Wang X. 3D organoids derived from the small intestine: An emerging tool for drug transport research. Acta Pharm Sin B 2021;11:1697-707. [PMID: 34386316 DOI: 10.1016/j.apsb.2020.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
54 Zhao Q, Cole T, Zhang Y, Tang SY. Mechanical Strain-Enabled Reconstitution of Dynamic Environment in Organ-on-a-Chip Platforms: A Review. Micromachines (Basel) 2021;12:765. [PMID: 34203533 DOI: 10.3390/mi12070765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Pu Y, Gingrich J, Veiga-Lopez A. A 3-dimensional microfluidic platform for modeling human extravillous trophoblast invasion and toxicological screening. Lab Chip 2021;21:546-57. [PMID: 33166377 DOI: 10.1039/d0lc01013h] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
56 Anagnostidis V, Sherlock B, Metz J, Mair P, Hollfelder F, Gielen F. Deep learning guided image-based droplet sorting for on-demand selection and analysis of single cells and 3D cell cultures. Lab Chip 2020;20:889-900. [PMID: 31989120 DOI: 10.1039/d0lc00055h] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 32.0] [Reference Citation Analysis]
57 Wasson EM, Dubbin K, Moya ML. Go with the flow: modeling unique biological flows in engineered in vitro platforms. Lab Chip 2021;21:2095-120. [PMID: 34008661 DOI: 10.1039/d1lc00014d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
58 Fransen MFJ, Addario G, Bouten CVC, Halary F, Moroni L, Mota C. Bioprinting of kidney in vitro models: cells, biomaterials, and manufacturing techniques. Essays Biochem 2021:EBC20200158. [PMID: 34096573 DOI: 10.1042/EBC20200158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
59 Wang H, Brown PC, Chow ECY, Ewart L, Ferguson SS, Fitzpatrick S, Freedman BS, Guo GL, Hedrich W, Heyward S, Hickman J, Isoherranen N, Li AP, Liu Q, Mumenthaler SM, Polli J, Proctor WR, Ribeiro A, Wang JY, Wange RL, Huang SM. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration. Clin Transl Sci 2021. [PMID: 33982436 DOI: 10.1111/cts.13066] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 18.0] [Reference Citation Analysis]
60 Nossa R, Costa J, Cacopardo L, Ahluwalia A. Breathing in vitro: Designs and applications of engineered lung models. J Tissue Eng 2021;12:20417314211008696. [PMID: 33996022 DOI: 10.1177/20417314211008696] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
61 Salman MM, Al-Obaidi Z, Kitchen P, Loreto A, Bill RM, Wade-Martins R. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases. Int J Mol Sci 2021;22:4688. [PMID: 33925236 DOI: 10.3390/ijms22094688] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 44.0] [Reference Citation Analysis]
62 Rauti R, Ess A, Roi BL, Kreinin Y, Epshtein M, Korin N, Maoz BM. Transforming a well into a chip: A modular 3D-printed microfluidic chip. APL Bioeng 2021;5:026103. [PMID: 33948527 DOI: 10.1063/5.0039366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
63 Rothbauer M, Bachmann BEM, Eilenberger C, Kratz SRA, Spitz S, Höll G, Ertl P. A Decade of Organs-on-a-Chip Emulating Human Physiology at the Microscale: A Critical Status Report on Progress in Toxicology and Pharmacology. Micromachines (Basel) 2021;12:470. [PMID: 33919242 DOI: 10.3390/mi12050470] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
64 Ryu YH, Moon SH, Kim KJ, Jun YJ, Oh DY, Kim SH, Rhie JW. A Novel Hypothesis and Characterization to Isolate Microvascular Endothelial Cells Simultaneously with Adipose-Derived Stem Cells from the Human Adipose-Derived Stromal Vascular Fraction. Tissue Eng Regen Med 2021;18:429-40. [PMID: 33877617 DOI: 10.1007/s13770-021-00332-5] [Reference Citation Analysis]
65 Powell-palm MJ, Charwat V, Charrez B, Siemons B, Healy KE, Rubinsky B. Isochoric supercooled preservation and revival of human cardiac microtissues.. [DOI: 10.1101/2021.03.22.436466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Kreutzer FP, Meinecke A, Schmidt K, Fiedler J, Thum T. Alternative strategies in cardiac preclinical research and new clinical trial formats. Cardiovasc Res 2021:cvab075. [PMID: 33693475 DOI: 10.1093/cvr/cvab075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
67 Makarczyk MJ, Gao Q, He Y, Li Z, Gold MS, Hochberg MC, Bunnell BA, Tuan RS, Goodman SB, Lin H. Current Models for Development of Disease-Modifying Osteoarthritis Drugs. Tissue Eng Part C Methods 2021;27:124-38. [PMID: 33403944 DOI: 10.1089/ten.TEC.2020.0309] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
68 Moysidou CM, Barberio C, Owens RM. Advances in Engineering Human Tissue Models. Front Bioeng Biotechnol 2020;8:620962. [PMID: 33585419 DOI: 10.3389/fbioe.2020.620962] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 23.0] [Reference Citation Analysis]
69 Liu L, Yu L, Li Z, Li W, Huang W. Patient-derived organoid (PDO) platforms to facilitate clinical decision making. J Transl Med 2021;19:40. [PMID: 33478472 DOI: 10.1186/s12967-020-02677-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 25.0] [Reference Citation Analysis]
70 Kohl Y, Biehl M, Spring S, Hesler M, Ogourtsov V, Todorovic M, Owen J, Elje E, Kopecka K, Moriones OH, Bastús NG, Simon P, Dubaj T, Rundén-Pran E, Puntes V, William N, von Briesen H, Wagner S, Kapur N, Mariussen E, Nelson A, Gabelova A, Dusinska M, Velten T, Knoll T. Microfluidic In Vitro Platform for (Nano)Safety and (Nano)Drug Efficiency Screening. Small 2021;17:e2006012. [PMID: 33458959 DOI: 10.1002/smll.202006012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
71 Kronemberger GS, Carneiro FA, Rezende DF, Baptista LS. Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening. Artif Organs 2021;45:548-58. [PMID: 33264436 DOI: 10.1111/aor.13880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
72 Yang C, Yang C, Yarden Y, To KKW, Fu L. The prospects of tumor chemosensitivity testing at the single-cell level. Drug Resist Updat 2021;54:100741. [PMID: 33387814 DOI: 10.1016/j.drup.2020.100741] [Reference Citation Analysis]
73 Farah CS, Celentano A, Pantaleo G, Shearston K, Fox S, Seyedasli N, Xaymardan M. Regenerative Approaches in Oral Medicine. Regenerative Approaches in Dentistry 2021. [DOI: 10.1007/978-3-030-59809-9_10] [Reference Citation Analysis]
74 El-hashash AH. Lung organoid culture system in pulmonary pathology and drug screening: an innovative test bed for basic and translational approaches. The Lung 2021. [DOI: 10.1016/b978-0-12-821206-6.00009-6] [Reference Citation Analysis]
75 Tambe V, Desai N, Rajpoot K, Tekade RK. “Organ-on-a-chip”-based physiologically relevant pharmacokinetic models. Biopharmaceutics and Pharmacokinetics Considerations 2021. [DOI: 10.1016/b978-0-12-814425-1.00024-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Potekhina ES, Bass DY, Kelmanson IV, Fetisova ES, Ivanenko AV, Belousov VV, Bilan DS. Drug Screening with Genetically Encoded Fluorescent Sensors: Today and Tomorrow. Int J Mol Sci 2020;22:E148. [PMID: 33375682 DOI: 10.3390/ijms22010148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
77 Peel S, Jackman M. Imaging microphysiological systems: a review. Am J Physiol Cell Physiol 2021;320:C669-80. [PMID: 33356942 DOI: 10.1152/ajpcell.00186.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Stein JM, Mummery CL, Bellin M. Engineered models of the human heart: Directions and challenges. Stem Cell Reports 2021;16:2049-57. [PMID: 33338434 DOI: 10.1016/j.stemcr.2020.11.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
79 Al-Majdoub ZM, Couto N, Achour B, Harwood MD, Carlson G, Warhurst G, Barber J, Rostami-Hodjegan A. Quantification of Proteins Involved in Intestinal Epithelial Handling of Xenobiotics. Clin Pharmacol Ther 2021;109:1136-46. [PMID: 33113152 DOI: 10.1002/cpt.2097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
80 Brevini T, Tysoe OC, Sampaziotis F. Tissue engineering of the biliary tract and modelling of cholestatic disorders. J Hepatol 2020;73:918-32. [PMID: 32535061 DOI: 10.1016/j.jhep.2020.05.049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
81 Cui Y, Zhao H, Wu S, Li X. Human Female Reproductive System Organoids: Applications in Developmental Biology, Disease Modelling, and Drug Discovery. Stem Cell Rev Rep 2020;16:1173-84. [PMID: 32929605 DOI: 10.1007/s12015-020-10039-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
82 Akpe V, Kim TH, Brown CL, Cock IE. Circulating tumour cells: a broad perspective. J R Soc Interface 2020;17:20200065. [DOI: 10.1098/rsif.2020.0065] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
83 Puryear Iii JR, Yoon JK, Kim Y. Advanced Fabrication Techniques of Microengineered Physiological Systems. Micromachines (Basel) 2020;11:E730. [PMID: 32731495 DOI: 10.3390/mi11080730] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
84 Peng Z, Zhou L, Wong JKW, Chan YK. Eye-on-a-chip (EOC) models and their role in the future of ophthalmic drug discovery. Expert Review of Ophthalmology 2020;15:259-61. [DOI: 10.1080/17469899.2020.1788388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
85 Richardson L, Kim S, Menon R, Han A. Organ-On-Chip Technology: The Future of Feto-Maternal Interface Research? Front Physiol 2020;11:715. [PMID: 32695021 DOI: 10.3389/fphys.2020.00715] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
86 Sanegre S, Lucantoni F, Burgos-Panadero R, de La Cruz-Merino L, Noguera R, Álvaro Naranjo T. Integrating the Tumor Microenvironment into Cancer Therapy. Cancers (Basel) 2020;12:E1677. [PMID: 32599891 DOI: 10.3390/cancers12061677] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
87 Griffiths NM, Van der Meeren A, Angulo JF, Vincent-naulleau S. Research on the Radiotoxicology of Plutonium Using Animals: Consideration of the 3Rs—Replace, Reduce, Refine. Health Physics 2020;119:133-40. [DOI: 10.1097/hp.0000000000001258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Lau HCH, Kranenburg O, Xiao H, Yu J. Organoid models of gastrointestinal cancers in basic and translational research. Nat Rev Gastroenterol Hepatol 2020;17:203-22. [PMID: 32099092 DOI: 10.1038/s41575-019-0255-2] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 33.0] [Reference Citation Analysis]
89 Nii T, Makino K, Tabata Y. A cancer invasion model of cancer-associated fibroblasts aggregates combined with TGF-β1 release system. Regen Ther 2020;14:196-204. [PMID: 32154334 DOI: 10.1016/j.reth.2020.02.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
90 Cota-Coronado A, Durnall JC, Díaz NF, Thompson LH, Díaz-Martínez NE. Unprecedented Potential for Neural Drug Discovery Based on Self-Organizing hiPSC Platforms. Molecules 2020;25:E1150. [PMID: 32143423 DOI: 10.3390/molecules25051150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
91 Wang Q, Dong X, Lu J, Hu T, Pei G. Constitutive activity of a G protein-coupled receptor, DRD1, contributes to human cerebral organoid formation. Stem Cells 2020;38:653-65. [PMID: 32052915 DOI: 10.1002/stem.3156] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
92 Messina A, Luce E, Hussein M, Dubart-Kupperschmitt A. Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration. Cells 2020;9:E420. [PMID: 32059501 DOI: 10.3390/cells9020420] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
93 Balakrishnan S, Atal S, Ray A, Pravin CA, Nanda M. Organoids: An invaluable tool in pharmacology. Indian J Pharmacol 2020;52:422-9. [PMID: 33283774 DOI: 10.4103/ijp.IJP_137_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
94 Pinsino A, Bastús NG, Busquets-fité M, Canesi L, Cesaroni P, Drobne D, Duschl A, Ewart M, Gispert I, Horejs-hoeck J, Italiani P, Kemmerling B, Kille P, Procházková P, Puntes VF, Spurgeon DJ, Svendsen C, Wilde CJ, Boraschi D. Probing the immune responses to nanoparticles across environmental species. A perspective of the EU Horizon 2020 project PANDORA. Environ Sci : Nano 2020;7:3216-32. [DOI: 10.1039/d0en00732c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
95 Yakimova MS, Aboushanab SAS, Ivantsova MN, Kamel M. Overview on 3D bioprinting technology: Potentials and current challenges. THE VII INTERNATIONAL YOUNG RESEARCHERS’ CONFERENCE – PHYSICS, TECHNOLOGY, INNOVATIONS (PTI-2020) 2020. [DOI: 10.1063/5.0035377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Van Norman GA. Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach? JACC Basic Transl Sci 2019;4:845-54. [PMID: 31998852 DOI: 10.1016/j.jacbts.2019.10.008] [Cited by in Crossref: 122] [Cited by in F6Publishing: 135] [Article Influence: 40.7] [Reference Citation Analysis]
97 Behura SK, Dhakal P, Kelleher AM, Balboula A, Patterson A, Spencer TE. The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy. Pharmacol Res 2019;149:104468. [PMID: 31600597 DOI: 10.1016/j.phrs.2019.104468] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
98 Tanner L, Single AB. Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance. J Innate Immun 2020;12:203-25. [PMID: 31527372 DOI: 10.1159/000502489] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
99 Chameettachal S, Yeleswarapu S, Sasikumar S, Shukla P, Hibare P, Bera AK, Bojedla SSR, Pati F. 3D Bioprinting: Recent Trends and Challenges. J Indian Inst Sci 2019;99:375-403. [DOI: 10.1007/s41745-019-00113-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
100 Cavero I, Guillon J, Holzgrefe HH. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates. Expert Opinion on Drug Safety 2019;18:651-77. [DOI: 10.1080/14740338.2019.1634689] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
101 Sung JH, Koo J, Shuler ML. Mimicking the Human Physiology with Microphysiological Systems (MPS). BioChip J 2019;13:115-26. [DOI: 10.1007/s13206-019-3201-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
102 Herrera C. The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: in vitro and ex vivo Models. Front Pharmacol 2019;10:578. [PMID: 31178736 DOI: 10.3389/fphar.2019.00578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
103 Tarantal AF, Batchelder CA. Scaffolds for kidney tissue engineering. Handbook of Tissue Engineering Scaffolds: Volume Two 2019. [DOI: 10.1016/b978-0-08-102561-1.00020-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]